Buy or sell Arria NLG stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Arria NLG Stock

Arria NLG is the leader in real-time data storytelling using Natural Language Generation (NLG) technologies.

About Arria NLG Stock

Arria is the leader in real-time data storytelling. Their core product is known as the Arria NLG Platform, a form of artificial intelligence software that specializes in extracting information from complex data sources and communicating that information in natural language. They configure the Platform for a wide range of client needs; and they also offer its technology as pre-packaged SaaS Products and as a Software Development Kit (SDK) via the NLG Cloud which has APIs that allow developers to add NLG functionality to their own applications. The scientific foundation for Arria NLG’s technology is based on more than 30 years of research and development. Arria’s scientists have authored over 300 academic papers on the subject, and their senior scientists wrote the de facto textbook in the field, ‘Building Natural Language Generation Systems’. Arria NLG’s early successes involved complex sensor data collection and analysis, an area in which the company’s engineers excel. The company’s current and future market strategy extends these capabilities to sophisticated automated reporting for business intelligence and finance operations. Headquartered in London with offices in New York, Aberdeen, Auckland and Sydney, Arria NLG serves markets across EMEA, North America and Asia Pacific. Arria NLG has a partnership with IBM Watson, using Watson’s question-answering functionality to incorporate compliance insights into data-driven reporting. Arria NLG also has a partnership with Genpact, whose Lean Digital products help companies automate finance operations like credit reporting and financial planning and analysis (FP&A). Their combined solution will allow companies to automate complex business processing and automatically generate affiliated finance and compliance reports. To find out more or discuss your use case with us, visit:

Funding History

November 2013$40.3M


Chairperson and Chief Executive Officer

Sharon Daniels

Company Secretary & General Counsel

Thomas Makeig

Chief Scientist

Ehud Reiter

Chief Operating Officer

Jay DeWalt

Non-Executive Director

Paul Kidney

Chief Development Scientist

Yaji Sripada


Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Arria NLG or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: